Thromboelastometry (TEM®) findings in disseminated intravascular coagulation in a pig model of endotoxinemia

Molecular Medicine

Volumn 17, Issue 3-4, 2011, Pages 226-272

  Schöchl, Herbert ^a,b   Solomon, Cristina ^c   Schulz, Arthur ^a,d   Voelckel, Wolfgang ^b   Hanke, Alexander ^e   van Griensven, Martijn ^a   Redl, Heinz ^a   Bahrami, Soheyl ^a  

^a LUDWIG BOLTZMANN INSTITUTE FOR EXPERIMENTAL AND CLINICAL TRAUMATOLOGY   (Austria)

^b AUVA Trauma Hospital   (Austria)

^c UNIVERSITY OF SALZBURG   (Austria)

^d AUVA Soziale Unfallversicherung   (Austria)

^e HANNOVER MEDICAL SCHOOL   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

LIPOPOLYSACCHARIDE; PLASMINOGEN ACTIVATOR INHIBITOR 1; TISSUE PLASMINOGEN ACTIVATOR;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BLOOD CLOT LYSIS; BLOOD CLOTTING TEST; BLOOD CLOTTING TIME; BLOOD SAMPLING; CONTROLLED STUDY; DISSEMINATED INTRAVASCULAR CLOTTING; ENDOTOXEMIA; EXPERIMENTAL PIG; FIBRIN BASED THROMBOELASTOMETRY; INTERMETHOD COMPARISON; INTERNATIONAL NORMALIZED RATIO; MALE; NONACTIVATED THROMBOELASTOMETRY; NONHUMAN; PARTIAL THROMBOPLASTIN TIME; PRIORITY JOURNAL; ROTATIONAL THROMBOELASTOMETRY; THROMBOELASTOMETRY; ANIMAL; BLOOD; BLOOD CELL COUNT; BLOOD CLOTTING; CHEMICALLY INDUCED DISORDER; DISEASE MODEL; DRUG EFFECT; FIBRINOLYSIS; METHODOLOGY; SWINE; THROMBOELASTOGRAPHY;

ANIMALS; BLOOD CELL COUNT; BLOOD COAGULATION; DISEASE MODELS, ANIMAL; DISSEMINATED INTRAVASCULAR COAGULATION; ENDOTOXEMIA; FIBRINOLYSIS; LIPOPOLYSACCHARIDES; MALE; PLASMINOGEN ACTIVATOR INHIBITOR 1; SWINE; THROMBELASTOGRAPHY; TISSUE PLASMINOGEN ACTIVATOR;

EID: 79952824971     PISSN: 10761551     EISSN: None     Source Type: Journal    
DOI: 10.2119/molmed.2010.00159     Document Type: Article

References (25)

1. Levi M, van der Poll T. (2010) Inflammation and coagulation. Crit. Care Med. 38:S26-34.
2. Mavrommatis AC, Theodoridis T, Orfanidou A, Roussos C, Christopoulou-Kokkinou V, Zakynthinos SG. (2000) Coagulation system and platelets are fully activated in uncomplicated sepsis. Crit. Care Med. 28:451-7.
3. Dixon B. (2004) The role of microvascular thrombosis in sepsis. Anaesth. Intensive Care 32:619-29.
4. Dhainaut J-F, et al. (2004) Treatment effects of drotrecogin alfa (activated) in patients with severe sepsis with or without overt disseminated intravascular coagulation. J. Thromb. Haemost. 2:1924-33.
5. Bakhtiari K, Meijers JCM, de Jonge E, Levi M. (2004) Prospective validation of the International Society of Thrombosis and Haemostasis scoring system for disseminated intravascular coagulation. Crit. Care Med. 32:2416-21.
6. Yu M, Nardella A, Pechet L. (2000) Screening tests of disseminated intravascular coagulation: guidelines for rapid and specific laboratory diagnosis. Crit. Care Med. 28:1777-80.
7. Levi M, ten Cate H (1999) Disseminated intravascular coagulation. N. Engl. J. Med. 341:586-92.
8. Mavrommatis AC, et al. (2001) Activation of the fibrinolytic system and utilization of the coagulation inhibitors in sepsis: comparison with severe sepsis and septic shock. Intensive Care Med. 27:1853-9.
9. van der Poll T, et al. (1991) Fibrinolytic response to tumor necrosis factor in healthy subjects. J. Exp. Med. 174:729-32.
10. Schöchl H, Solomon D, Voelckel W. (2010) Thromboelastometry in the perioperative setting. Neth. J. Crit. Care 14:23-31.
11. Schöchl H, et al. (2010) Goal directed coagulation management of major trauma patients using trhomboelastometry guided administration of fibrinogen concentrate and prothormbin complex concentrate. Crit. Care 14:R55.
12. Schmidhammer R, Wassermann E, Germann P, Redl H, Ullrich R. (2006) Infusion of increasing doses of endotoxin induces progressive acute lung injury but prevents early pulmonary hypertension in pigs. Shock 25:389-94.
13. Velik-Salchner C, et al. (2006) Normal values for thrombelastography (ROTEM) and selected coagulation parameters in porcine blood. Thromb. Res. 117:597-602.
14. Levi M, de Jonge E, Meijers J. (2002) The diagnosis of disseminated intravascular coagulation. Blood Rev. 16:217-23.
15. Taylor FB Jr, Toh CH, Hoots WK, Wada H, Levi M. (2001) On behalf of the Scientific Subcommittee on Disseminated Intravascular Coagulation (DIC) of the International Society on Thrombosis and Haemostasis: towards definition, clinical and laboratory criteria and a scoring system for disseminated intravascular coagulation. Thromb. Haemost. 86:1327-30.
16. Collins PW, et al. (2006) Global tests of haemostasis in critically ill patients with severe sepsis syndrome compared to controls. Br. J. Haematol. 135:220-7.
17. Luddington RJ. (2005) Thrombelastography/ thromboelastometry. Clin. Lab. Haematol. 27:81-90.
18. Schöchl H, Frietsche T, Pavelka M, Jambor C. (2009) Hyperfibrinolysis following major trauma: differential diagnosis of lysis patterns and prognostic value of thromboelastometry. J. Trauma 67:125-31.
19. Sivula M, Pettila V, Niemi TT, Varpula M, Kuitunen AH. (2009) Thromboelastometry in patients with severe sepsis and disseminated intravascular coagulation. Blood Coagul. Fibrinolysis 20:419-26.
20. Daudel F, Kessler U, Folly H, Lienert JS, Takala J, Jakob SM. (2009) Thromboelastometry fort the assessment of coagulation abnormalities in early and established adult sepsis: a prospecctive cohort study. Crit. Care 13:R42.
21. Adamzik M, et al. (2010) Comparison of thromboelastometry with procalcitonin, interleukin 6, and C-reactive protein as diagnostic tests for severe sepsis in critically ill adults. Crit. Care 14:R178
22. Zacharowski K, Sucker C, Zacharowski P, Hartmann M. (2006) Thrombelastography for the monitoring of lipopolysaccharide induced activation of coagulation. Thromb. Haemost. 95:557-61.
23. Spiel AO, Mayr FB, Firbas C, Quehenberger P, Jilma B. (2006) Validation of rotation thrombelastography in a model of systemic activation of fibrinolysis and coagulation in humans. J. Thromb. Haemost. 4:411-6.
24. Park MS, et al. (2009) Thromboelastography as a better indicator of hypercoagulable state after injury than prothrombin time or activated partial thromboplastin time. J. Trauma 2:266-75.
25. Suffredini AF, Harpel PC, Parrillo JE. (1989) Promotion and subsequent inhibition of plasminogen activation after administration of intravenous endotoxin to normal subjects. N. Engl. J. Med. 320:1165-72.